Share：
Share this content in WeChat
X
[Chinese][PDF]162080
• Review •
Research progress of magnetic resonance T2-mapping in body malignant tumors
ZHU Liuhong  LIU Hao  ZHOU Jianjun 

Cite this article as: Zhu LH, Liu H, Zhou JJ. Research progress of magnetic resonance T2-mapping in body malignant tumors. Chin J Magn Reson Imaging, 2020, 11(5): 398-400. DOI:10.12015/issn.1674-8034.2020.05.019.


[Abstract] With the rapid development of magnetic resonance imaging technologies and big data era, the diagnosis of tumors does not only depend on imaging manifestations. How to quantitatively evaluate the characteristics of tumors has gradually become a hot research issue. T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), diffusion weighted imaging (DWI) and dynamic contrast enhancement (DCE) techniques have become routine sequences during the daily MRI scanning at present. The signal intensity on the weighted images cannot directly reflect the characteristics of the tissue. As one of the MR quantitative technologies, T2 mapping is objective, reproductive and stable, and has been frequently applied to the researches about osteoarthritis and myocardial edema. With the development of MR imaging, it has been applied to the studies of body tumor gradually in recent years. This article reviews the progress about quantitative research of T2 mapping in body tumors.
[Keywords] magnetic resonance imaging；T2 mapping；breast cancer；prostate cancer

ZHU Liuhong Department of Radiology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen 361015, China

LIU Hao Department of Radiology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen 361015, China

ZHOU Jianjun* Department of Radiology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen 361015, China

*Corresponding to: Zhou JJ, E-mail: zhou.jianjun@zs-hospital.sh.cn

Conflicts of interest   None.

ACKNOWLEDGMENTS  This paper is supported by the Guiding Project Fund of Xiamen Science and Technology Bureau No. 3502Z20199040
Received  2019-10-06
Accepted  2020-03-26
DOI: 10.12015/issn.1674-8034.2020.05.019
Cite this article as: Zhu LH, Liu H, Zhou JJ. Research progress of magnetic resonance T2-mapping in body malignant tumors. Chin J Magn Reson Imaging, 2020, 11(5): 398-400. DOI:10.12015/issn.1674-8034.2020.05.019.

[1]
Garcia-Reyes K, Passoni NM, Palmeri ML, et al. Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis. Abdominal Imaging, 2015, 40(1): 134-142.
[2]
Deoni SCL, Rutt BK, Peters TM. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Reson Med, 2003, 49(3): 515-526.
[3]
McKenzie CA, Chen Z, Drost DJ, et al. Fast acquisition of quantitative T2 maps. Magn Reson Med, 2003, 49(3): 515-526.
[4]
Crooijmans HJA, Scheffler K, Bieri O. Finite RF pulse correction on DESPOT2. Magn Reson Med, 2011, 65(3): 858-862.
[5]
Fan Z, Sheehan J, Bi X, et al. 3D noncontrast MR angiography of the distal lower extremities using flow-sensitive dephasing (FSD)-prepared balanced SSFP. Magn Reson Med, 2009, 62(6): 1523-1532.
[6]
McPhee KC, Wilman AH. Transverse relaxation and flip angle mapping: evaluation of simultaneous and independent methods using multiple spin echoes. Magn Reson Med, 2017, 77(5): 2057-2065.
[7]
Lebel RM, Wilman AH. Transverse relaxometry with stimulated echo compensation. Magn Reson Med, 2010, 64(4): 1005-1014.
[8]
Basiri R, Federico P, Lebel RM. Transverse relaxometry with transmit field-constrained stimulated echo compensation. Magn Reson Mater Phy, 2019, 32(6): 669-677.
[9]
Yamauchi FI, Penzkofer T, Fedorov A, et al. Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T2- mapping MRI sequence. Magn Reson Imaging, 2015, 33(5): 525-530.
[10]
Van Houdt PJ, Agarwal HK, van Buuren LD, et al. Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T2 mapping across multiple syste ms. Magn Reson Med, 2017, 79(3): 1586-1594.
[11]
Sabouri S, Fazli L, Chang SD, et al. MR measurement of luminal water in prostate gland: Quantitative correlation between MRI and histology. J Magn Reson Imaging, 2017, 46(3): 861-869.
[12]
Mai J, Abubrig M, Lehmann T, et al. T2 Mapping in Prostate Cancer. Invest Radiol, 2019, 54(3): 146-152.
[13]
Giganti F, Gambarota G, Moore CM, et al. Prostate cancer detection using quantitative T2 and T2-weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance. J Magn Reson Imaging, 2018, 47(6):1646-1653.
[14]
Sabouri S, Chang SD, Savdie R, et al. Luminal water imaging: a new MR imaging T2 mapping technique for prostate cancer diagnosis. Radiology, 2017, 284(2): 451-459.
[15]
Tan PC, Pickles MD, Lowry M, et al. Lesion T2 relaxation times and volumes predict the response of malignant breast lesions to neoadjuvant chemotherapy. Magn Reson Imaging, 2008, 26(1): 26-34.
[16]
Liu L, Yin B, Shek K, et al. Role of quantitative analysis of T2 relaxation time in differentiating benign from malignant breast lesions. J Int Med Res, 2018, 46(5): 1928-1935.
[17]
孟凡星，卢再鸣，郭启勇,等．磁共振T2 mapping成像在乳腺病变良恶性鉴别诊断中的应用．中国临床医学影像杂志, 2013, 24(5): 317-320.
[18]
Ghosh A, Singh T, Bagga R, et al. T2 relaxometry mapping in demonstrating layered uterine architecture: parameter optimisation and utility in endometrial carcinoma and adenomyosis: a feasibility study. Br J Radiol, 2018, 91(1081): 20170377.
[19]
李淑健，程敬亮，张勇,等. T2 mapping成像评估宫颈癌病理学特征.中国医学影像技术, 2019, 35(9): 1365-1369.
[20]
Carter JS, Koopmeiners JS, Jessica E, et al. Quantitative multiparametric MRI of ovarian cancer. J Magn Reson Imaging, 2013, 38(6): 1501-1509.
[21]
Hueper K, Lang H, Hartleben B, et al. Assessment of liver ischemia reperfusion injury in mice using hepatic T2 mapping: comparison with histopathology. J Magn Reson Imaging, 2018, 48(6): 1586-1594.
[22]
Luetkens JA, Klein S, Träber F, et al. Quantification of Liver Fibrosis at T1 and T2 mapping with extracellular volume fraction MRI: preclinical Results. Radiology, 2018, 288(3): 748-754.
[23]
Zhang H, Yang Q, Yu T, et al. Comparison of T2, T1rho, and diffusion metrics in assessment of liver fibrosis in rats. J Magn Reson Imaging, 2017, 45(3): 741-750.
[24]
Hoffman DH, Ayoola A, Nickel D. et al. T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis. Abdom Radiol, 2019, 24. DOI:
[25]
Cieszanowski A, Anysz-Grodzicka A, Szeszkowski W, et al. Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. Eur Radiol, 2012, 22(11): 2514-2524.
[26]
Yamada I, Yoshino N, Hikishima K, et al. Colorectal carcinoma: Ex vivo evaluation using 3-T high-spatial-resolution quantitative T2 mapping and its correlation with histopathologic findings. Magn Reson Imaging, 2017, 38: 174-181.
[27]
Adams LC, Bressem KK, Jurmeister P, et al. Use of quantitative T2 mapping for the assessment of renal cell carcinomas: first results. Cancer Imaging, 2019, 19(1): 35.
[28]
Karnik T, Mcbean R, Hart G, et al. Novel MRI of mediastinal masses: Internal differentiation of a thymoma and lymphoma with T1 and T2 mapping. BMJ Case Reports, 2018, 2018(pii): bcr-2017-224119.

PREV Research progress of medical image texture analysis in musculoskeletal diseases
NEXT Evaluation of the relationship between pituitary macroadenomas and cranial nerves in the cavernous
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn